The Norwegian Radium Hospital, The Research Building
CCB congratulates Guro Lind with the Oncological Forum Young Researcher award 2011. The prize was awarded to Guro Lind at the Oncological Forum annual meeting held at Holmenkollen Park Hotel in Oslo on Friday the 18th of November.
- article about CCB in International Innovation publication. As part of the Centre for Cancer Biomedicine dissemination programme, we have decided to participate in Research Media’s International Innovation publication.
- for her outstanding research on mechanisms of downregulation of growth factor receptors.
In a recent issue of Science (Nov 4 2011), Hilde Abrahamsen and Harald Stenmark at the Institute for Cancer Research and Centre for Cancer Biomedicine discuss novel progress in our understanding of how cells respond to increased amino acid levels to turn on growth.
The research on nanoparticles and their cellular interactions, performed by Tore-Geir Iversen and his colleagues at the Centre for Cancer Biomedicine, has gained considerable international attention after the interview with Iversen entitled “Nanoparticles can hinder intracellular transport” was published on the Norwegian Research Council’s web pages.
The cover of the September 2011 issue of the journal Traffic displays 3D-reconstructions of endosomes recorded by two postdocs in Harald Stenmark’s group at the Institute for Cancer Research and Centre for Cancer Biomedicine, Lene Malerød and Nina Marie Pedersen (Malerød is now senior scientist in Trond Lehren’s group at Department of Medical Genetics).
The Norwegian Cancer Society highlights one research project each month, and in September 2011 the project obtaining attention is directed by CCB’s senior researcher Tor Erik Rusten.
CCB director Harald Stenmark from the Department of Biochemistry at the Institute for Cancer Research has recently been elected Fellow of The European Academy of Cancer Sciences.
The Research Council of Norway has recently completed a mid-term evaluation of 8 Centres of Excellence that were inaugurated in 2007. We are pleased to announce that Centre for Cancer Biomedicine (CCB) was ranked with the highest obtainable score, “exceptionally good”.
A figure from the review article “Cell polarity and migration: Emerging role of the endosomal sorting machinery”, by CCB’s Viola Lobert and Harald Stenmark, was chosen for the cover of the June 2011 issue of “Physiology”.
Professor Sverre Heim received King Olav V’s Cancer Research Award in a ceremony on the 14th of June where His Majesty King Harald V handed over the prestigious cancer prize to Sverre Heim, the prize winner from Centre for Cancer Biomedicine, Institute for Medical Informatics.
Under the last call for “large-scale research infrastructure”, the proposal “A national subcellular imaging platform” was recently approved by the Research Council of Norway for contract negotiations within a total budget of 20.5 Mkr.
A review article about in vitro studies of nanoparticles was recently published in Nano Today (journal impact factor 13.3) by Tore-Geir Iversen, Tore Skotland and Kirsten Sandvig.
In the March 25th issue of Science, Camilla Raiborg and Harald Stenmark at the Centre for Cancer Biomedicine and Institute for Cancer Research are contributing a Perspective article that covers recent developments in our understanding of the molecular dynamics of the final stage of cell division – cytokinesis.
In a recent issue of Oncogene, two project leaders at the Centre for Cancer Biomedicine and Institute for Cancer Research, cancer geneticist Guro E. Lind (Ragnhild A. Lothe’s group) and cell biologist Camilla Raiborg (Harald Stenmark’s group), present a promising biomarker for early detection of colon cancer.
The work performed in the Sandvig group is highlighted in an article in Lab times.
The “Journal of Cell Biology” (impact factor 9.6) has in the February 21st issue brought an interview with Harald Stenmark from the Department of Biochemistry at the Institute for Cancer Research.
The popular Norwegian research web site “forskning.no” has interviewed CCB’s Tore-Geir Iversen about his work on nanoparticles.
We are pleased to announce that Marco Novelli from the University College London, has accepted to become Visiting Professor in CCB.